Manifold BioManifold Bio
Manifold Bio

Manifold Bio

AI-guided drug discovery platform for tissue-targeted medicines.

2018Active68
Rate

About

Manifold Bio is a biotechnology company developing an AI-guided, high-throughput in vivo (HTV) discovery engine. Their platform integrates massively multiplexed in vivo screening with AI-powered protein design to create targeted biologics, optimizing properties like pharmacokinetics and biodistribution directly within living systems. They aim to accelerate the development of tissue-targeted medicines for various diseases.

Technology stack

detected 2026-06-24
Est. monthly stack spend~$690/mo
CDN
Cloudflare
EmailGoogle Workspace
Stack
Tailwind CSSBootstrapWebflow
Analytics
Google Tag Manager
Video
Vimeo
Hiring
Greenhouse
Stack from job poststools named in active roles
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Manifold Bio do?

Manifold Bio is a biotechnology company developing an AI-guided, high-throughput in vivo (HTV) discovery engine. Their platform integrates massively multiplexed in vivo screening with AI-powered protein design to create targeted biologics, optimizing properties like pharmacokinetics and biodistribution directly within living systems. They aim to accelerate the development of tissue-targeted medicines for various diseases.

How much funding has Manifold Bio raised?

Manifold Bio has raised a total of $118M in funding. The most recent round on record is Series B.

Where is Manifold Bio headquartered?

Manifold Bio is headquartered in Boston, United States.

When was Manifold Bio founded?

Manifold Bio was founded in 2018.

What industry does Manifold Bio operate in?

Manifold Bio operates in Biotech, Drug Discovery, AI-Driven Drug Design, Protein Engineering, Therapeutics, Life Sciences.

How many employees does Manifold Bio have?

Manifold Bio has approximately 68 people on record.